Prostate cancer Board decisions

The Veteran's claim for an initial compensable rating for prostate cancer residuals is being remanded due to a failure to obtain an adequate VA examination before the January 2022 rating decision.

The Veteran's service-connected prostate cancer and kidney disease have precluded him from obtaining or maintaining substantially gainful employment since June 28, 2018. His effective date for TDIU is set at June 28, 2018, and DEA benefits are also granted on the same date.

The Veteran's appeal for a total disability rating based on individual unemployability (TDIU) is being remanded due to the need for additional information regarding his employment and income history.

The Veteran's death was caused by diabetes mellitus and prostate cancer, which are presumed to be service-connected due to exposure to herbicides. Service connection for the cause of death is granted.

The Board denied the appellant's claims for a disability rating in excess of 20 percent for residuals of prostate cancer with voiding dysfunction and for continuance of SMC based on housebound criteria from January 1, 2022. The reduction to a 20 percent disability rating was proper as the appellant's prostate cancer was in remission.

The Veteran's claimed disabilities, including left shoulder, right shoulder, right knee, left knee, right foot, and left foot disabilities, as well as bilateral hearing loss, hypertension, and prostate cancer, were not incurred or aggravated during service. The Board found that the evidence did not establish a nexus between these conditions and service.

The Board has remanded the Veteran's claim for service connection for prostate cancer due to exposure at Camp Lejeune, as there is insufficient evidence to establish service connection and a VA examination is required.

The Veteran's claims for service connection are remanded due to conflicting evidence regarding his exposure to herbicides and the need for a VA medical opinion.

The Board denied the Veteran's claims for earlier effective dates for service connection due to lack of new and material evidence within one year of final decisions, and because the Veteran did not have exposure to herbicide agents under the PACT Act.

The Board has decided to remand the case due to a duty-to-assist error and requires another VA examination related to the Veteran's prostate cancer.

The Board denied an increased rating for the Veteran's prostate cancer residuals, maintaining a 20% disability rating effective April 1, 2022. The evidence did not support a higher rating due to lack of active malignancy.

The Veteran's service connection claims for coronary artery disease and prostate cancer are granted due to presumed exposure to herbicide agents in Guam, effective October 1, 2022.

The Veteran's claims for service connection for prostate cancer and diabetes mellitus, type II were granted effective August 10, 2021.,Erectile dysfunction was also granted as secondary to the service-connected diabetes mellitus.

The Board has decided to remand the case due to a lack of an adequate medical opinion regarding whether the Veteran's prostate cancer is related to service or caused by his service-connected prostatitis. The claim will be reconsidered with new evidence.

The Veteran's prostate cancer is granted as service-connected due to presumed exposure to herbicide agents in American Samoa under the PACT Act. The claim was reopened and new evidence was received.

The Veteran withdrew their appeal for service connection of prostate cancer, and the Board has dismissed the case.

The Veteran's claims for increased ratings and effective dates are being remanded due to the lack of medical records from a critical period.

The Veteran's bilateral pulmonary nodules, coronary artery disease, prostate cancer, and aortic aneurysm are all granted service connection due to exposure to herbicide agents. The effective date is not specified as the decision was for initial ratings.

The Veteran's prostate cancer is being remanded for further evaluation due to the need for a medical opinion regarding its relationship to service, specifically his exposure at Camp LeJeune.

The Veteran's prostate cancer and coronary artery disease are presumed to be related to his in-service exposure to herbicides, specifically Agent Orange. As such, the claims for service connection are granted.